Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Paracetamol 1000 mg/Codeine 30 mg vs Co-efferalgan
NCT02902666Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Apr 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of acetaminophen and codeine in pain (2 arms), sponsored by Angelini Pharma. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to Last Measurable Concentration. Started Apr 2016; status: completed.
02
Drugs
acetaminophencodeine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02902666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02902666.